🔎 Trials Near Me

Gara Jalqabaatti › Cufama Onnee › Minnesota › Minneapolis

Qorannoo klinikaalii Cufama Onnee Minneapolis, MN keessatti

Qorannoo 21 Cufama Onnee f Minneapolis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

ELEVATE-HFpEF Clinical Study

Namoota walitti qabaa jira
  • M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06678841

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Namoota walitti qabaa jiraSadarkaa 3
  • Minneapolis VA Health Care System, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Namoota walitti qabaa jiraSadarkaa 3
  • Minneapolis VA Health Care System, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06424288

Alleviant ALLAY-HFrEF Study

Namoota walitti qabaa jira
  • Minneapolis Heart Institute Foundation, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • University of Minnesota, Minneapolis
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Minneapolis
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Namoota walitti qabaa jiraSadarkaa 3
  • Minneapolis, MN Investigative Site CON-10035, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Namoota walitti qabaa jiraSadarkaa 3
  • Minneapolis, MN Investigative Site 10091, Minneapolis
  • Minneapolis, MN Investigative Site 10035, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Namoota walitti qabaa jira
  • Abbott Northwestern Hospital, Minneapolis
  • University of Minnesota, Minneapolis
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06310031

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Minneapolis, Minneapolis
Umuriin hundi · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT00271180

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Minneapolis Heart Institute Foundation, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Namoota walitti qabaa jiraSadarkaa 3
  • Tenax Investigational Site, Minneapolis
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07288398

Alleviant ALLAY-HF Study

Namoota walitti qabaa jira
  • Minneapolis Heart Institute Foundation, Minneapolis
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT05685303

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Namoota walitti qabaa jira
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT05996328

Assessment of CCM in HF With Higher Ejection Fraction

Namoota walitti qabaa jira
  • Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05064709

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

Namoota walitti qabaa jiraSadarkaa 3
  • Minneapolis, MN Investigative Site FIN-10035, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Namoota walitti qabaa jira
  • University of Minnesota, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Namoota walitti qabaa jira
  • Minneapolis Heart Institute, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT06526195

CCM OPEN HF Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Minneapolis Heart Institute Research Foundation, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT07112924

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Minneapolis Heart Institute Foundation, Minneapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Mud-2025 · NCT07131631

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 22-Cam-2024 · NCT06425848

Qorannoo Cufama Onnee magaalota biroo keessatti

Qorannoo biroo Minneapolis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.